This nanocarrier resulted in higher suppression of RA progression in an AIA rat model that non-targeted IL-27 liposomes or free IL-27, with a significant decrease in transaminases levels, cartilage damage and bone erosion. Here, IL27 is linked to rheumatoid arthritis.